Stay updated on FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.

Latest updates to the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a minor backend or formatting update without changes to study information.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.6.3 is now shown, replacing the previous v3.6.0. This appears to be a minor maintenance update to the page’s versioning rather than a substantive change to the study information.SummaryDifference0.0%

- Check53 days agoChange DetectedNew guidance and navigation sections have been added to help users read the study record and join the study. Recruitment status indicates no longer looking for participants, and the page revision was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check60 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a maintenance or feature update to the page rendering.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 on the page, indicating a newer version of the content.SummaryDifference0.0%

- Check104 days agoChange DetectedThe version/release label at the bottom of the page was updated from Revision: v3.5.0 to Revision: v3.5.3.SummaryDifference0.0%

Stay in the know with updates to FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.